Home

personaggio scatola eccesso borsa molmed coda Montagna Coraggioso

Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed:  the Board of Directors approves the Issuer's not
Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed: the Board of Directors approves the Issuer's not

MolMed - Wikipedia
MolMed - Wikipedia

I giapponesi di Agc l'anciano un'Opa su Molmed e il titolo corre in borsa
I giapponesi di Agc l'anciano un'Opa su Molmed e il titolo corre in borsa

1 - [Note: this notice is the English translation of the official version  of the 102 notice which will be in Italian language]
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]

MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK  for high-risk leukaemia in the United States
MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK for high-risk leukaemia in the United States

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY  OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER

MolMed, viaggio nell'officina dei superfarmaci per le terapie geniche - Il  Sole 24 ORE
MolMed, viaggio nell'officina dei superfarmaci per le terapie geniche - Il Sole 24 ORE

Relazione sulla Remunerazione MolMed S.p.A.
Relazione sulla Remunerazione MolMed S.p.A.

Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza  - Affaritaliani.it
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it

Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana

MolMed now part of AGC Biologics | LinkedIn
MolMed now part of AGC Biologics | LinkedIn

Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR  RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA
Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA

MolMed - YouTube
MolMed - YouTube

L'ok Ue fa volare Molmed (+11%) - MilanoFinanza.it
L'ok Ue fa volare Molmed (+11%) - MilanoFinanza.it

Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor  immunity in pancreatic cancer - ScienceDirect
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer - ScienceDirect

European Population Genetic Substructure: Further Definition of Ancestry  Informative Markers for Distinguishing among Diverse European Ethnic Groups  | Molecular Medicine | Full Text
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text

Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini

European Population Genetic Substructure: Further Definition of Ancestry  Informative Markers for Distinguishing among Diverse European Ethnic Groups  | Molecular Medicine | Full Text
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text

MolMed: Contact Details and Business Profile
MolMed: Contact Details and Business Profile

Innovazione, la Borsa corre con plastica e super batteri - Corriere.it
Innovazione, la Borsa corre con plastica e super batteri - Corriere.it

MolMed: AIFA approva commercializzazione Zalmoxis. Titolo vola in Borsa -  Economia e Finanza - Repubblica.it
MolMed: AIFA approva commercializzazione Zalmoxis. Titolo vola in Borsa - Economia e Finanza - Repubblica.it

Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR  RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART
Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART

Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE

Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their  Association with Age-Related Disorders
Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their Association with Age-Related Disorders